Zentalis Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Zentalis Pharmaceuticals, Inc. (ZNTL) had Shares Outstanding (Cover Page) of 71.67 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 71.67M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 71.19M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 70.93M shares.
- 2025-11-01: Entity Common Stock, Shares Outstanding 72.25M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 71.67M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 71.19M shares 10-Q · filed 2026-05-12 |
| 2026-03-20 | 70.93M shares 10-K · filed 2026-03-26 |
| 2025-11-01 | 72.25M shares 10-Q · filed 2025-11-10 |
| 2025-08-01 | 72.14M shares 10-Q · filed 2025-08-06 |
| 2025-05-12 | 71.95M shares 10-Q · filed 2025-05-14 |
| 2025-03-21 | 71.81M shares 10-K · filed 2025-03-26 |
| 2024-11-01 | 71.27M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 71.11M shares 10-Q · filed 2024-08-09 |
| 2024-05-03 | 71.01M shares 10-Q · filed 2024-05-07 |
| 2024-02-22 | 70.96M shares 10-K · filed 2024-02-27 |
| 2023-11-02 | 70.77M shares 10-Q · filed 2023-11-06 |
| 2023-08-07 | 70.61M shares 10-Q · filed 2023-08-09 |
| 2023-05-08 | 59.48M shares 10-Q · filed 2023-05-10 |
| 2023-02-27 | 59.42M shares 10-K · filed 2023-03-01 |
| 2022-11-07 | 57.07M shares 10-Q · filed 2022-11-09 |
| 2022-08-08 | 56.98M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 46.63M shares 10-Q · filed 2022-05-05 |
| 2022-02-22 | 45.56M shares 10-K/A · filed 2022-10-31 |
| 2021-11-09 | 45.31M shares 10-Q · filed 2021-11-10 |
| 2021-08-06 | 45.05M shares 10-Q · filed 2021-08-12 |
| 2021-05-07 | 41.31M shares 10-Q · filed 2021-05-17 |
| 2021-03-24 | 41.04M shares 10-K · filed 2021-03-25 |
| 2020-11-05 | 40.61M shares 10-Q · filed 2020-11-09 |
| 2020-08-11 | 40.00M shares 10-Q · filed 2020-08-13 |
| 2020-05-10 | 35.88M shares 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |